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1. Introduction  
Endocytosis is a process that occurs in all eukaryotes and is an essential mechanism for 
internalizing membrane proteins and controlling intracellular trafficking (Bishop, 2003). 
Membrane proteins such as active epidermal growth factor receptors (EGFRs) are 
endocytosed via clathrin-dependent or independent-pathways and are typically first 
delivered to the early endosome (Bishop, 1997; Tarrago-Trani & Storrie, 2007) (Figure 1). 
The early endosomes (or sorting endosomes) have a crucial role in sorting the 
endocytosed cargo to three alternative destinations: (i) recycling the cargo back to the 
plasma membrane (receptor sequestration), (ii) transferring the cargo to the trans Golgi 
network (TGN), (iii) transporting the cargo into intraluminal vesicles (ILVs) of maturing 
endosomes known as multivesicular bodies (MVBs) (reviewed by Gruenberg & Stenmark, 
2004; Russel et al., 2006; Piper & Katzmann, 2007). The ultimate consequence of such 
sorting is the exposure of the ILVs and their contents to lysosomal hydrolases after fusion 
of the MVB with lysosomes (receptor down-regulation) (reviewed by Sorkin & von 
Zastrow, 2009; Wegner et al., 2011). MVBs also play an important role in the traffic of 
lysosomal enzymes from the TGN, and in the secretion of exosomes from cells (Lakkaraju 
& Rodriguez-Boulan, 2008; Simons & Raposo, 2009, Thery et al., 2009). MVBs functions 
extend beyond cargo sorting - they also serve as MHC class II compartments for antigen 
presentation, T-cell secretory granules and melanosomes in specialised cell types (Raiborg 
et al., 2003).  
Efficient sorting at the early endosome and the MVB compartments typically requires mono- 
or polyubiquitination of cell surface receptors. The molecular machinery that recognises the 
ubiquitinated cargo at the early endosome and mediates its sorting into MVBs is a set of 
interacting protein complexes, the endosomal complexes required for transport (ESCRTs’). 
The ESCRTs’ were first identified in yeast and were initially referred to as class E Vps 
(vacuolar protein sorting) proteins (Raymond et al., 1992). Characterisation of the 18 class E  
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Fig 1. Interrelationships between the endocytic and autophagic pathways.  
(a) Receptor-mediated endocytosis involves internalization of plasma membrane cargo into 
the cell. Endocytosed cargo is first delivered to the early endosome, which also receives 
cargo from the TGN. From here on, selected cargo can be delivered to three alternative 
destinations: (i) can be recycled back to the plasma membrane (receptor sequestration), or 
(ii) sorted into the TGN or (iii) incorporated into ILVs of MVBs. The cargo within the MVB 
compartment is subsequently transported to the lysosome where the constituents are broken 
down by lysosomal hydrolases (receptor down-regulation). The MVB biogenesis and the 
sorting of ubiquitinated cargo is controlled by four ESCRTs’, -0, -I, -II -III, and the action of a 
AAA+ type ATPase Vps4. (b) In contrast to endocytosis, autophagy digests intracellular 
material by encapsulating damaged organelles or protein aggregates by a phagophore. The 
resulting autophagosome can fuse directly with the lysosome forming an autolysosome or 
indirectly via the MVB compartment forming a hybrid organelle, termed an amphisome.  
genes revealed that ten of these encode subunits of the ESCRT system, whereas the others 
encode ESCRT-related proteins or upstream or downstream interactors (reviewed by 
Slagsvold et al., 2006) (Table 1).    
Extensive genetic, biochemical and structural studies using yeast, Drosophila and 
mammalian model systems have revealed the molecular roles of the ESCRTs’. The ESCRT 
system consists of four different complexes termed ESCRT-0, -I, -II and –III, and a number 
of associated proteins such as Vps4 (Babst et al., 2002a, 2002b; Katzmann et al., 2001) 
(Figure 2). Ubiquitinated endosomal cargo targeted for lysosomal degradation is initially 
recognised by ESCRT-0. ESCRT-I, -II and -III which are subsequently recruited to the 
endosomal membrane by protein-protein interactions between the four complexes 
(reviewed by Roxrud et al., 2010). The ubiquitinated cargo is further concentrated on the 
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endosomal membrane by the action of ESCRT-I and –II, furthermore invaginations that 
form from the endosomal membrane to become ILVs depend upon ESCRT-III and Vps4 -
facilitated membrane abscission (Elia et al., 2011; Babst et al., 2011). The endocytosed 
contents in the ILVs are ultimately terminated via lysosomal degradation (Figure 1). 
Following protein sorting into MVBs, the ATPase Vps4 catalyzes the release of the ESCRT 
machinery from the limiting membrane of the MVB compartment into the cytosol for 
further rounds of cargo sorting. 
The ESCRTs’ also have alternative cellular roles beyond lysosomal trafficking. A subset of 
ESCRTs’ have a well-established function in eukaryotic cell abscission (cytokinesis) (Spitzer 
et al., 2006; Carlton & Martin-Serrano, 2007; Morita et al., 2007), viral budding (Morita & 
Sundquist, 2004; Fujii et al., 2007) and autophagy (Filimonenko et al., 2007; Lee et al., 2007). 
Given their importance in fundamental cellular processes, it is not surprising that ESCRT 
dysfunction is associated with numerous diseases, including neurodegenerative disorders, 
cancer and infectious diseases. The dynamics and regulation of the ESCRT machinery have 
been extensively reviewed (Hurley & Emr, 2006; Saksena et al., 2007; Williams & Urbe, 2007; 
Raiborg & Stanmark, 2009; Hanson et al., 2009; Carlton & Martin-Serrano, 2009; Hurley, 
2010; Roxrud et al., 2010; Henne et al., 2011) and will only be mentioned briefly here. This 
review focuses on understanding the role of the ESCRTs’ in disease using model systems, to 
better understand the mechanisms behind their role in pathogenesis. 
2. Evolutionary conservation of ESCRTs’ 
Comparative genomic and phylogenetic analysis has revealed in great detail the 
conservation of the molecular machineries involved in cargo sorting and membrane 
trafficking. The phylogenetic data has shown that most ESCRT genes emerged early during 
the evolution of eukaryotes (Slater & Bishop, 2006, Field et al., 2007; Leung et al., 2008, Field 
& Dacks, 2009). However the ESCRT-III complex and Vps4 have been identified in Archaea, 
suggesting an even earlier, ancestral function for these components (Lindas et al., 2008; 
Ghazi-Tabatabai et al., 2009; reviewed by Makarova et al., 2010; Samson et al., 2008, 2011). It 
has even been suggested a similar mechanism may contribute to bacterial outer membrane 
vesicle production (Kulp & Kuehn, 2011). All of the other ESCRT complexes with the 
exception of ESCRT-0, are present across all of the eukaryotic lineages. ESCRT-0 appears to 
be specific to the opisthokonts (metazoa and fungi) and is absent from Dictyostelium 
discoideum, a member of their sister lineage the Amoebozoa, as well as from plants (Winter & 
Hauser, 2006; Leung et al., 2008; Field & Dacks, 2009). However D. discoideum contains 
instead a minimal, possibly ancestral ESCRT-0 in which DdTom1 interacts with ubiquitin, 
clathrin and the ESCRT-1 protein Tsg101 (Blanc et al., 2009). MVBs were also recently 
identified in the basal amoebozoan Breviata anathema, strengthening the conclusion that the 
ESCRTs’ are a common feature of this supergroup (Herman et al., 2011). In mammals and 
plants several VpsE genes such as Vps37, Vps4, Vps32, Mvb12 and Bro1 have undergone gene 
duplications. The domain structure of VpsE proteins, especially the domains involved in 
protein-protein and protein-lipid interactions is well conserved across yeast, metazoa and 
plants (reviewed by Michelet et al., 2010) (Table 1). Collectively, these data suggests that the 
fundamental structure and the role of the ESCRTs’ is well conserved among many 
eukaryotic organisms.  
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ESCRT complex and  
activity 
Yeast  
Protein names 
Metazoan  
Protein names 
Domains/Motifs1 Biological function 
ESCRT-0 
Clusters ubiquitinated 
cargo 
Vps27  
 
 
Hse1 
Hrs 
 
 
STAM1, 2 
VHS, FYVE, UIM (yeast) DUIM 
(metazoan), PTAP, GAT, coiled-coil 
core, clathrin binding  
VHS, UIM, SH3, GAT, coiled-coil 
core, clathrin binding 
Binds PtdIns3P, ubiqutinated 
 
 
Binds ubiquitinated cargo an
ESCRT-I 
Membrane deformation 
and budding 
 
Vps23 
Vps28 
Vps37 
Mvb12 
Tsg101 
Vps28 
Vps37A, B, C, D 
MVB12A, B 
UEV, Pro-rich linker, stalk, headpiece  
Headpiece, C-terminal 
Basic helix, head piece 
Stalk, ubiquitin binding domain 
Cargo and ESCRT-0 (Vps27) interaction, 
Binds ESCRT-II (Vps36)  
Binds membranes 
Stabilizes ESCRT-I subunits
ESCRT-II 
Membrane deformation 
and budding  
Vps22 
Vps25 
Vps36 
EAP30, Snf8 
EAP20 
EAP45 
Coiled-coil, WH 
PPXY, WH 
GLUE, NZF1, 2 (yeast), WH 
Binds membranes 
Binds ESCRT-III (Vps20), cargo 
Binds membranes, ubiquiti
ESCRT-III 
Membrane scission 
 
Vps20 
Vps32/* (Snf7) 
Vps24  
Vps2/(Did4) 
CHMP6 
CHMP4A, B, C 
CHMP3  
CHMP2A, B 
Charged, coiled-coil, MIM 
Charged, coiled-coil, MIM 
Charged, coiled-coil, MIM 
Charged, coiled-coil, MIM 
Initiates membrane scission 
Membrane scission, binds Bro
Completes membrane scissio
Recruits Vps4; initiates ESCRT di
Vps4 
Disassembly of ESCRTs’  
 
Vps4 
 
Vps4A,B/(SKD1, 
2) 
 
 
AAA+ ATPase, MIT 
 
ESCRT disassembly and recycling 
 Vta1 VTA1/LIP5 MIT, VSL Positively  regulates of Vps4
 
Other  
Vps31/(Bro1) ALIX/AIP1 Bro1, Proline-rich domain ESCRT-III interaction by recruiting 
apoptosis regulators, contain
 Vps60/(Mos10) CHMP5 Charged, coiled-coil ESCRT-III like protein, binds 
 Vps46/(Did2)  CHMP1A, B Charged, coiled-coil ESCRT-III like protein, recruits Vps4  
 Ist1 IST1 MIM1, MIM2 The tandem ESCRT III doma
 Doa4 UBPY/USP8 Rhod, UBP Removes ubiquitin  
 
1Domain acronyms: Bro1, Bro1 domain-containing protein 1; CHMP, charged multivesicular body protein; DID, DOA
protein; DUB, deubiquitylating enzyme; DUIM, double-sided ubiquitin-interacting motif; ESCRT, endosomal sorting
GAT; GLUE, GRAM-like ubiquitin-binding in EAP45; Hrs, hepatocyte growth factor-regulated Tyr kinase substrate; I
protein 1; MIM, MIT-interacting motif; MIT, microtubule-interacting and transport; MVB, multivesicular body; NZF,
homology 3; UBPY, ubiquitin isopeptidase Y; UEV, ubiquitin E2 variant; UIM, ubiquitin-interacting motif; VHS, Vps
protein sorting; VSL and VTA1; WH2, winged helix 2. *Alternative names are provided in brackets. 
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3. Structure and function of ESCRTs’ in normal cells 
3.1 Composition of the ESCRT complexes 
In order to understand the role of the ESCRTs’ in disease, a brief overview of the 
composition of each complex is provided (Figure 2). ESCRT-0, -I and –II are stable 
heterotetrameric complexes, while ESCRT-III is formed by polymers formed by four core 
protein subunits. 
 
Fig. 2. Composition and molecular interactions of the ESCRTs’.  
Interactions between the four ESCRTs’ are indicated, as are interactions with ubiquitylated 
cargo, accessory molecules such as phosphatidylinositol 3-phosphate (PtdIns(3)P), 
deubiquitylating enzymes (DUBs), Bro1 and the ATPase Vps4. Yeast protein names have 
been used but the figure above is a composite of data obtained from studies of several 
model systems containing the ESCRTs’. 
3.1.1 ESCRT-0 
The ESCRT-0 complex has an early role in MVB biogenesis and in the sorting of 
ubiquitinated proteins into the MVB pathway. ESCRT-0 binds and clusters ubiquitinated 
cargo destined for delivery into MVBs, and recruits clathrin and deubiquitinating enzymes 
(Wollert et al., 2010). The ESCRT-0 complex consists of two subunits, Hrs (Vps27 in yeast) 
and STAM1/2 (Hse1 in yeast). Hrs contains a FYVE zinc finger domain which binds 
PtdIns(3)P providing membrane recruitment and endosomal specificity for the ESCRT-0 
complex (Mao et al., 2000). Hrs and STAM1/2 bind ubiquitin via their UIM and VHS 
ubiquitin domains respectively, which are essential for efficient sorting of ubiquitinated 
proteins (Bishop et al., 2002; Mizuno et al., 2003; Bache et al., 2006). Hrs binds directly to the 
tumour susceptibility gene–101 product (Tsg101) recruiting ESCRT-I to the endosomal 
membranes (Bishop et al., 2002) (Figure 2).   
3.1.2 ESCRT-I 
The ESCRT-I complex along with ESCRT-II is required for further concentrating 
ubiquitinated cargo on the endosomal membrane and initiating the first stages of membrane 
invagination (Wollert et al., 2010). Mammalian ESCRT-I is composed of four subunits 
Tsg101 (Vps23 in yeast), Vps28, Vps37 (four isoforms, A-D) and Mvb12 (two isoforms A/B); 
the yeast ESCRT-I contains single copies of the four subunits (Chu et al., 2006; Curtiss et al., 
2007; Kostelansky et al., 2007; Oestreich et al., 2007) (Figure 2). A novel ESCRT-I component 
was recently identified in mammalian cells, termed UBAP1. UBAP1 contains a region 
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conserved in Mvb12 and binds Bro1 proteins involved in cytokinesis (Stefani et al., 2011). 
The ESCRT-I structure is organised as a headpiece core with flexibly connected modules 
that mediate interactions with other partners such as ESCRT-0, ubiquitin, Alix (Bro1 in 
yeast) and ESCRT-II. The Tsg101 subunit can also directly bind Vps20, an ESCRT-III 
component, surpassing both ESCRT-I and –II (Katzmann et al., 2003; Bilodeau et al., 2003; 
Pornillos et al., 2003).  
3.1.3 ESCRT-II    
The ESCRT-II complex is recruited to the endosomal membrane by the interaction between 
the ESCRT-I subunit Vps28 and the ESCRT-II subunit Vps36 (Saksena et al., 2009) (Figure 2). 
The ESCRT-II complex is a heterotetramer with one copy of Vps22 and Vps36 and two 
copies of Vps25 (Hierro et al., 2004; Im & Hurley, 2008; Teis et al., 2010). Mammalian Vps36 
binds PtdIns(3)P and ubiquitin via the GLUE domain and is important for efficient cargo 
sorting (Teo et al., 2006). The yeast Vps36 contains a GLUE domain with two NZF 
insertions. NZF1 binds to ESCRT-I (Gill et al., 2007) and NZF2 binds to ubiquitinated cargo 
(Alam et al., 2004). The C-terminal domain of Vps25 provides a direct link to ESCRT-III by 
binding to CHMP6 (Vps20).   
3.1.4 ESCRT-III 
The ESCRT-III complex plays an important role in membrane scission and is responsible for 
pinching off the neck of the invagination, forming an ILV (Wollert et al, 2009, Wollert & 
Hurley, 2010) (Figure 2). Mammalian ESCRT-III consists of multiple subunits, CHMP2 (two 
isoforms A/B,) (in yeast Vps2), CHMP3 (in yeast Vps24), CHMP4 (four isoforms A-D) (in 
yeast Snf7), and CHMP6 (in yeast Vps20) (Babst et al, 2002a; Bajorek et al., 2009b). The other 
ESCRT-III subunits CHMP1 (two isoforms A/B), (in yeast Did2), CHMP5 (in yeast Vps60) 
and Ist1 are not strictly essential for function and appear to assemble with the rest of the 
ESCRT-III subunits at a later stage. Did2 and Vps60 recruit and activate Vps4, while Ist1 
inhibits Vps4 activity (Nickerson et al., 2006; Dimaano et al., 2008). Vps4 is an AAA-ATPase, 
which has an important role in catalysing and energizing the dissociation of the ESCRT 
machinery form the endosomal membrane back to the cytosol, for further rounds of cargo 
sorting. The ESCRT-III complex does not bind ubiquitin, however it recruits Alix, which 
plays a key role in the endosomal recruitment of Doa4, a deubiquitinating enzyme (Babst et 
al., 1997; 1998; Scott et al., 2005; Muziol et al., 2006; Shim et al., 2007; Yu et al., 2008; Teis et 
al., 2008; Lata et al., 2008; Ghazi-Tabatabai et al., 2009). 
3.2 Biological roles of the ESCRTs’ 
3.2.1 Cytokinesis  
In eukaryotes, cytokinesis consists of at least three key steps: (i) assembly of the central 
spindle, (ii) formation of the cleavage furrow, (iii) and membrane abscission at the midbody 
(Yang et al., 2008; reviewed by Saksena & Emr, 2009). The membrane scission and the 
creation of the membrane curvature required in cytokinesis is topologically similar to the 
curvature needed during MVB sorting and viral budding. Studies have shown that 
components of ESCRTs’ are required for membrane abscission, the final step of cytokinesis. 
For instance, ESCRT-III is specifically recruited to the midbody to mediate membrane fission 
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and Vps4 is important in the release of ESCRT-III in cytokinesis (Spitzer et al., 2006; Obita et 
al., 2007; Carlton & Martin-Serrano, 2007). Furthermore, depletion of either Ist1 and Did2 
(ESCRT-III and Vps4 human homologues) leads to an arrest in cytokinesis (Agromayor et 
al., 2009; Bajorek et al., 2009a). Additionally, the ESCRT-I subunit Tsg101 and the ESCRT-III 
associated protein Alix were found to competitively associate with Cep55 (a multimeric cell 
division protein essential for late stage cell division) to facilitate recruitment of ESCRT-III 
and Vps4 for abscission of the two daughter cells (Carlton & Martin-Serrano, 2007; Morita et 
al., 2007). The role of ESCRT-II in cytokinesis is unclear, although studies conducted by 
Langelier et al., 2006 indicate that Vps22 of ESCRT-II is located on the centrosomes and is 
involved in the maturation of these organelles. The mechanisms behind ESCRT mediated 
scission and their role in microtubule disassembly have been recently reviewed in detail by 
Henne et al., 2011 and Roxrud et al., 2010 and will not be further discussed in this review.  
3.2.2 Autophagy  
In the mammalian system there are two pathways that intersect with the lysosome, the MVB 
pathway as described in the introduction and the autophagy pathway. To date, three 
autophagy pathways have been described in higher eukaryotes: microautophagy (MA), 
chaperone-mediated autophagy (CMA) and macroautophagy (Mizushima et al., 2008; 
Cuervo, 2010). Microautophagy was originally described in yeast, but is not yet well 
characterised in other eukaryotes (Marzella et al., 1981). In this pathway, the lysosome 
invaginates and internalizes cytosolic components, which are subsequently degraded in the 
lumen of the lysosome. Chaperone-mediated autophagy is a more selective autophagy that 
does not involve vesicle formation but rather a direct translocation of a specific set of 
proteins across the lysosomal membrane. The cytosolic chaperone hsc70, a major component 
of the CMA pathway recognises the pentapeptide ‘KFERQ’ sequence in proteins destined 
for lysosomal degradation (Sahu et al., 2011). The lysosome-associated protein type 2A 
(LAMP2A) binds and translocates the KFERQ proteins to the lysosome, through a yet-
unclear-mechanism (Orenstein & Cuervo, 2010; reviewed by Shpilka & Elazar, 2011). A 
recent study has identified a new macroautophagy-like degradation pathway that is distinct 
from CMA and occurs in lysosomes (Orenstein & Cuervo, 2010). Endosomal 
microautophagy was shown by Sahu et al., 2011 to occur during MVB formation and 
requires both ESCRT-I and –III, as well as hsc70 for delivery of KFERQ proteins from the 
cytosol into MVBs. This study provided fresh insights into the mechanisms of autophagy in 
mammalian model systems and also extended the role of ESCRTs’ to degradation of 
cytosolic compartments. The role of the ESCRTs’ is best characterized in macroautophagy 
and this will be the focus here.  
Macroautophagy (henceforth simply referred to as autophagy) is a bulk degradation 
pathway responsible for the removal of damaged organelles and for clearance of protein 
aggregates (reviewed by Mehrpour et al., 2010). The fundamental molecular mechanisms of 
the autophagy pathway have been extensively studied in yeast, using genetic screening to 
identify autophagy genes (atg) (Klionsky et al., 2003). Subsequent inactivation of atg 
orthologues in higher eukaryotes has shown that the autophagic machinery is highly 
conserved. The autophagic pathway involves multiple steps: (i) sequestration of cytoplasmic 
constituents by a double membrane phagophore, resulting in the formation of an 
autophagosome and (ii) direct fusion of autophagosomes with the lysosome, where the 
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cytoplasmic material is degraded in the resulting autolysosome or alternatively (iii) fusion 
of the autophagosome with the MVB compartment, forming a hybrid component termed an 
amphisome, which then fuses with the lysosome (Lawrence & Brown, 1992; Berg et al., 1998; 
Liou et al., 1997) (Figure 1). 
Many age-related neurodegenerative disorders are characterised by an accumulation of 
ubiquitin-positive aggregates in affected brain regions. Autophagy is necessary for the 
clearance of these proteins, as aggregates essentially become toxic for postmitotic cells like 
neurons (reviewed by Eskelinen & Saftig, 2009). Defects in the autophagic pathway are 
associated with neurodegenerative diseases such as Alzheimer’s, Huntington’s and 
Parkinson’s diseases. For instance, in Alzheimer’s disease (AD) neuronal autophagy is 
activated in the early stages, however autophagic degradation becomes impaired as the 
disease progresses (Boland et al., 2008). Similarly in Huntington’s disease (HD), active 
autophagy helps in the clearance of toxic polyglutamine-containing proteins (Ravikumar et 
al., 2004). In Parkinson’s disease (PD) mutant α-synuclein blocks its own degradation via the 
chaperone-mediated autophagy pathway resulting in a gain-of-function neurotoxicity 
(Cuervo et al., 2004).  
Studies conducted using slime moulds, nematodes, flies and mammals as model systems to 
study neurodegenerative disease have revealed that the ESCRT machinery plays a role in 
autophagy. Genetic disruption of ESCRT-I, -II and -III in mammalian and Drosophila cells 
leads to an increase in autophagosomes and toxic protein aggregates increase the severity of 
HD (Lee et al., 2009). Similarly, in rodent cortical neurons, loss of the CHMP2B subunit 
leads to an accumulation of autophagosomes (Lee et al,. 2007). Autophagosome and 
amphisome accumulation was also observed in HeLa cells when Tsg101 and 
CHMP3/Vps24 were knocked down or CHMP2B was disrupted (Lee et al., 2007). 
Consistent with the above data, downregulation of Vps4 in HeLa cells resulted in 
autophagosome accumulation, impaired degradation of autophagy substrates and impaired 
delivery of endosomal constituents to autophagosomes (Nara et al., 2002). The observed 
increase in autophagosomes suggests that there is either an enhanced initiation of 
autophagy in the cell or a decreased autophagic flux. The ESCRT machinery is therefore 
predicted to be involved in one or more key stages of the autophagic pathway. The 
possibilities include: (i) ESCRTs’ are involved in signalling pathways that induce autophagy, 
(ii) ESCRTs’ are required for phagophore closure or (iii) ESCRTs’ are involved in the fusion 
of autophagosomes with the lysosome and/or the fusion of the autophagosomes with the 
MVB (reviewed by Rusten & Stenmark, 2009).  
To date, little is known about the underlying mechanisms allowing the ESCRTs’ to mediate 
fusion of autophagosomes with the MVB compartment and lysosomes. It has been shown 
that tethering of lysosomes to endosomes and autophagosomes is mediated by Rab7 (Bucci 
et al., 2000, Gutierrez et al., 2004; Jager et al., 2004) and the HOPS complex, which brings the 
membranes in close proximity (Wurmser et al., 2000; Seals et al., 2000; reviewed by Metcalf 
& Isaacs, 2010). ESCRT proteins interact directly with the HOPS complex which binds Rab7, 
as determined by a recent study which revealed that mutant CHMP2B (an ESCRT-III 
subunit) leads to impaired recruitment of Rab7 (Urwin et al., 2010). This suggests that 
functional ESCRTs’ are required either for recruiting the vesicular fusion machinery to the 
MVB compartment or for delivery of the fusion machinery to lysosomes or 
autophagosomes. A number of other proteins are also implicated in autophagosome fusion 
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with endosomes/lysosomes including UVRAG, Rubicon and LAMP-2. It is not yet known 
whether the ESCRT machinery has an effect on these proteins and processes.  
3.2.3 Downregulation of receptor-mediated signaling 
Receptor tyrosine kinases (RTKs) are growth factor receptors that play a important 
regulatory roles in controlling cell growth, proliferation, differentiation, survival and 
metabolism in several tissues and organs (Hunter, 2000; Pawson et al., 2001). Dysfunction of 
RTKs or mutations in key components of their downstream signaling pathways results in a 
variety of diseases, such as cancer, diabetes, immune deficiencies and cardiovascular 
disorders (Blume-Jensen & Hunter, 2001). EGFR is one of the best studied RTKs, and its 
uncontrolled signaling is associated with the development of a number of human cancers, 
including mammary carcinomas, squamous carcinomas and glioblastomas (Hunter, 2000; 
Pawson et al., 2001).  The multivesicular body pathway silences RTK signaling via lysosome 
sequestration and degradation and thus plays an important role in modulating the 
amplitude and kinetics of amide signaling pathways from activated receptors (Saksena et 
al., 2007; Hurley & Emr, 2006; Williams & Urbe, 2007). Defects in ESCRT-mediated sorting of 
these receptors to lysosomal degradation pathways can thus lead to sustained receptor 
signaling either because of prolonged residence and activity in the endosomal membrane or 
as a result of increased recycling of the receptors to the plasma membrane. 
Drosophila studies have shown that EGFR degradation is impaired and signalling is 
prolonged by dysfunctional ESCRT-0 (Hrs) (Lloyd et al., 2002), ESCRT-I (Tsg101) (Vaccari & 
Bilder, 2005) or ESCRT-II (Vps25) (Thompson et al., 2005). In mammals, depleting Tsg101 
causes sustained EGFR signaling (Bache et al., 2006), whereas depletion of CHMP3 (ESCRT-
III) (Bache et al., 2006) or Eap30 (ESCRT-II) (Malerod et al., 2007) causes delayed EGFR 
degradation but not sustained signaling (Table 2). Sustained signaling observed in ESCRT-0, 
-I and -II Drosophila mutants and after ESCRT-I depletion in mammals may result from 
increases in the residence time of receptors in the endosomal membrane and their recycling 
back to the plasma membrane. Mutations in ESCRT-III subunits do not cause sustained 
signaling (Bache et al., 2006), possibly because ESCRT–III recruitment occurs after signal 
termination. This may also explain why ESCRT-III subunits so far have not been implicated 
in cancer.  
The Notch signaling pathway is highly conserved from Drosophila to humans and plays a 
central role in the normal development of many tissues and cell types. It controls various 
effects on differentiation, survival, and/or proliferation that are highly dependent on signal 
strength and cellular context. Dysfunction of the Notch signaling pathway leads to many 
human diseases such as lung and skin cancer (Radtke & Raj, 2003; Allenspach et al., 2002). 
Studies in Drosophila have shown that Notch signaling is terminated via lysosomal 
degradation suggesting a role for the ESCRT machinery in the regulation of Notch. In 
Drosophila, depletion of Hrs or mutation of Tsg101 or Vps25 leads to an accumulation of the 
cell-surface receptors Notch, Delta, Thickveins and EGFR (Thompson et al., 2005; Vaccari & 
Bilder, 2005; Moberg el al., 2005). Notch accumulation stimulates cell proliferation in the eye 
disc (Chao et al., 2004, Tsai & Sun, 2004) and results in overgrowth phenotypes in 
surrounding wild-type cells via the JAK/STAT pathway. Furthermore, inactivation of 
Tsg101 or Vps5 in Drosophila results in loss of epithelial cell polarity, which is associated 
with malignant transformation, suggesting that ESCRT components have a role in 
www.intechopen.com
 
Current Frontiers and Perspectives in Cell Biology 462 
organizing the actin and/or microtubule cytoskeleton (Thompson et al., 2005; Vaccari & 
Bilder, 2005; Moberg el al., 2005; Saksana & Emr, 2009). In summary, there is growing 
evidence that implicates functional ESCRTs’ in suppressing malignant transformation and 
preventing cancer. 
4. The roles of ESCRTs’ in disease 
4.1 Neurodegenerative diseases 
The most direct evidence that ESCRT dysfunction causes neurodegenerative disease comes 
from the identification of autosomal dominant CHMP2B mutations found to cause a rare 
form of frontotemporal dementia (FTD3) (Skibinski et al., 2005) and amyotrophic lateral 
sclerosis (ALS) (Parkinson et al., 2006). FTD is the second most common form of early-onset 
dementia after Alzheimer’s disease (Ratnavalli et al., 2002; Harvey et al., 2003) and is 
characterised by the presence of either tau neurofibrillary tangles or ubiquitin deposits. FTD 
with the presence of tau or ubiquitin pathology is termed FTLD-U (frontotemporal lobar 
degeneration with ubiquitin-immunoreactive inclusions) (Neary et al., 2005). Both FTLD-U 
and ALS are characterised by abnormal accumulation of ubiquitin-positive protein deposits 
(including TDP-43) that contain p62, tau and α-synuclein-negative neuronal cytoplasmic 
inclusions (Arai et al., 2006; Neumann et al., 2006). The adapter protein p62 is commonly 
found in protein inclusions associated with neurodegenerative disease (Talbot & Ansorge, 
2006), it binds polyubiquitin (Vadlamudi et al., 1996) and interacts with the autophagic 
associated protein Atg8/LC3 (Bjorkoy et al., 2005; Pankiv et al., 2007). Collectively, these 
data implicate p62 as a link between protein accumulation and aggregation with autophagy-
mediated clearance (reviewed by Saksena & Emr, 2009). Similarly, ESCRT-depleted cells and 
cells overexpressing CHMP2 in flies, mice and humans, showed impaired autophagic 
degradation leading to an accumulation of autophagosomes and protein aggregates 
containing p62, thereby contributing to the pathogenesis of FTD3. A recent study has shown 
that deletion of the ESCRT proteins Tsg101 and Vps24 resulted in accumulation of TDP-43, 
suggesting that impaired MVB function could have a role in TDP-43 aggregate formation in 
FTLD-U and ALS (Filimonenko et al., 2007). Furthermore, Vps24 was found to be essential 
in the clearance of expanded polyglutamine aggregates associated with Huntington’s 
disease (Table 2) (Filimonenko et al., 2007). Collectively, these data suggest that efficient 
autophagic degradation requires functional ESCRTs’ and dysfunction of this machinery is 
associated with neurodegenerative phenotypes and disorders.   
Several indirect links also implicate the ESCRTs’ in various neurodegenerative disorders, and 
several ESCRT-interacting proteins are products of genes that are associated with inherited 
forms of neurodegeneration (reviewed by Stuffers et al., 2009a). For instance, in mice, a null 
mutation in Mahoganin, an E3 ubiquitin ligase that ubiquitinates Tsg101, causes spongiform 
neurodegeneration, a recessively transmitted prion-like disease (Kim, et al., 2007; Jiao et al., 
2009). Two putative ESCRT-III interacting proteins, spartin and spastin are mutated in spastic 
paraplegia, an inherited neurodegenerative disease that paralyzes the lower limbs (Reid et al., 
2005). The exact mechanism of CHMP4 contribution to this disease remains unclear and 
requires further investigation. Finally, Niemann-Pick disease type C is an inherited 
neurodegenerative disorder characterized by a disruption of lipid trafficking and is caused by 
a mutation in either of the two genes, npc1 and npc2 (reviewed by Eskelinen & Saftig, 2009). A 
dominant-negative mutant of Vps4 was found to cause an accumulation of ubiquitinated 
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NPC1 (Ohsaki et al., 2006). Together, these data indicate that dysregulation of ESCRT 
pathways may contribute to a broad spectrum of degenerative diseases.    
4.2 Cancer 
The first hint that ESCRTs’ play a role in cancer came from the identification of Tsg101 and 
Vps37A as tumour suppressor genes on the basis that they map to chromosomal regions 
deleted or mutated in cancer (Li & Cohen, 1996; Xu et al., 2003). Genomic deletions and 
splice variants of Tsg101 were found in sporadic forms of breast cancer (Li et al., 1997) and 
other malignancies such as myeloid leukaemia and prostate cancer (Table 2) (Sun et al., 
1997; Lin et al., 1998). In addition, Vps37A expression in hepatocellular carcinomas was 
found to be dramatically reduced or undetected suggesting that Vps37A may be a potential 
tumour suppressor (Xu et al., 2003). Similar results were observed with CHMP1A, as 
overexpression of this protein inhibited cell growth and tumour formation in human 
pancreatic tumor cells (Li et al., 2009).  
Mutations that prevent c-Cbl-mediated ubiquitination of EGFRs and thereby inhibit ESCRT-
mediated receptor down-regulation are associated with a number of cancers, particularly 
acute myeloid leukemia. For example, a mutant EGFR lacking only the direct c-Cbl-binding 
site transduces stronger mitogenic signals when compared to the wild-type receptor 
(Waterman et al., 2002; Saksena & Emr, 2009). The c-Met RTK (also known as HGFR) 
regulates invasive growth and is critical for normal development and wound repair. Its 
overexpression causes uncontrolled proliferation and growth and consequently is associated 
with a variety of human cancers (Haddad et al., 2001). In part c-Cbl-mediated ubiquitination 
controls cellular c-Met levels and therefore ubiquitination and functional ESCRTs’ are 
needed to avoid c-Met-related malignant transformation (Peschard et al., 2001). 
Collectively, the foregoing studies indicate that the ESCRTs’ have a negative regulatory role 
in growth receptor signaling, however several independent studies have shown that 
ESCRTs’ also have a positive role in growth factor signaling. For instance, Tsg101 was 
recently found to be overexpressed, rather then reduced in breast, thyroid, ovarian and 
colon cancer (Ma et al., 2008). Furthermore, depletion of Tsg101 prevented tumorigenicity in 
several cancer lines (Zhu et al., 2004). To further support ESCRTs’ positive role in oncogenic 
signaling, the ESCRT-0 component Hrs was found to be essential for cell proliferation and 
tumorigenesis in both HeLa and mouse fibroblast cells (Toyoshima et al., 2007).  
A positive regulatory role in growth factor signalling for the ESCRTs’ has also been 
observed in Drosophila melanogaster (Vaccari et al., 2005; Thompson et al., 2005; Moberg et al., 
2005; Vaccari et al., 2009; Herz et al., 2006; Rodahl et al., 2009). For example, Tsg101 is 
essential for normal cell growth and cell survival in the fruit fly and clonal loss of this gene 
in epithelial cells causes hyperplasia of surrounding tissue despite the mutant cells dying 
via apoptosis (Moberg et al., 2005; reviewed by Stuffers et al., 2009a). Loss of Vps25 causes a 
similar effect, whereas loss of Hrs is without effect (Vaccari & Bilder, 2005; Thompson et al., 
2005). It is important to note that the proapoptotic signaling pathways Hippo, JNK and Hid 
are activated in the Vps25 Drosophila mutants. Expression of the caspase inhibitor p35 in the 
Vps25 mutant cells restores cell growth and even results in overgrowth, suggesting that 
mutations in both the ESCRT pathway and the apoptotic pathway are required for 
overgrowth. Blocking apoptosis by expressing Ark (an essential component of the apoptotic 
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pathway) or Diap1 (Drosophila inhibitor of apoptosis protein 1), again results in overgrowth 
of the Vps25 mutant tissue. Collectively, these results suggest that the ESCRTs’ in Drosophila 
do not act as conventional tumor suppressors.  
Overall, the ESCRTs’ have been implicated in both positive and negative roles in growth 
factor receptor signaling and cancer, suggesting that the exact role of the ESCRTs’ in 
tumourigenesis may be cell-type and context-dependent. Alternatively, ESCRT-mediated 
actions in controlling cell proliferation may reflect diverse endosomal sorting roles on a 
broad range of molecular targets with many different roles in cellular homeostasis 
(reviewed by Lobert & Stenmark, 2011). Further research needs to be conducted using 
different model systems to better understand the complex roles of the ESCRTs’ in signaling 
and cell proliferation. More specifically, future studies need to address whether ESCRTs’ act 
as genuine tumour suppressors in mammals, since at this stage this is still unclear. 
4.3 Infectious diseases 
4.3.1 Microbial infections 
The endocytic and autophagic pathways play an important role in innate immunity. Multiple 
studies have now shown that these host cell pathways can be manipulated by viruses and 
microorganisms in order to facilitate infection (von Schwedler et al., 2003; Vieira et al., 2004; 
Philips et al., 2008; Morita & Sundquist, 2004; Martin-Serrano & Marsh, 2007; McCullough et 
al., 2008). ESCRTs’ play an important role in degenerative endosomal trafficking, so it is not 
surprising that they are involved in killing many microorganisms. For example, functional 
ESCRTs’ have been shown to restrict mycobacterial growth and infection (Philips et al., 2008). 
Mycobacteria may invade macrophages and are able to survive and replicate intracellularly 
due to their ability to prevent fusion of bacteria-containing phagosomes with lysosomes. In 
both the Drosophila model system, and in mammalian macrophages, mutation of ESCRTs’ 
renders cells susceptible to mycobacterial infections. Similarly, overexpression of Vps4 in the 
host cell results in deficient differentiation and virulence of the intracellular protozoal 
pathogen Leishmania major (Table 2) (Vieira et al., 2004; Philips et al., 2008). Furthermore, 
autophagosome accumulation was also observed, and both functional endosomal and 
autophagic pathways are required for optimal L. major virulence and infection (Besteiro et al., 
2006). The mechanisms by which ESCRTs’ mediate resistance to microbial infection have not 
been defined. It is possible that ESCRTs’ are required for the delivery of the pathogen to the 
lysosome, more specifically having a role in phagosome maturation and fusion between the 
phagosome and lysosome. Like the involvement of the ESCRTs’ in the autophagic pathway 
these results suggest that the ESCRTs’ affect multiple cellular trafficking events. The finding 
that ESCRT components restrict the growth of intracellular microbial pathogens means that 
they can now be considered as therapeutic targets for treatment of these infections which cause 
millions of deaths every year.  
In the case of eukaryotic pathogens, the ESCRTs’ of the pathogen may also play important 
roles in virulence. Candida albicans causes opportunistic fungal infections and its ESCRT 
proteins have multiple roles in pathogenesis. The fungal ESCRT components are suggested 
to contribute to diverse fungal functions including cell signaling, nutrient acquisition and 
possibly cell wall architecture (Cornet et al., 2005; Wolf et al., 2010). However the role of 
ESCRTs’ in candidiasis is not yet fully understood. 
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Table 2. ESCRT-associated diseases in various model systems 
(Modified from Stuffers et al., 2009a) 
References: 1Toyoshima et al., 2007; 2Xu et al., 2003; 3Young et al., 2007; 4Young et al., 2007; 5Oh et al., 2007; 
6Liu et al., 2002; 7Koon et al., 2004; 8Moberg et al., 2005; 9Vaccari & Bilder et al., 2005; 10Thompson et al., 
2005; 11Wilson et al., 2001; 12Walker et al., 2006; 13Gutmann et al., 2001; 14Scoles et al., 2002; 15Li et al., 2008; 
16Parkinson et al., 2006; 17 Skibinski et al., 2005; 18Filimonenko et al., 2007; 19Rusten et al., 2007; 20Lee et al., 
2007; 21 Kim et al., 2007; 22 Shirk et al., 2005; 23Reid et al., 2005;  24Vieira et al., 2004; 25Cornet et al., 2005; 
26Wolf et al., 2011;  27Babst et al., 1998; 28Spitzer et al., 2006; 29Besteiro et al., 2006; 30Shiels et al., 2007. 
Complex Component Dysfunction/disease Pathogenesis Model systems 
Cancer     
ESCRT-0 Hrs (Vps27) Tumourigenesis and 
metastatic potential 
Hrs depletion is associated with 
the upregulation of E-cadherin 
and reduced β-catenin signalling1 
Human cancer 
cells, MEF, mice 
ESCRT-0 associated Hrs (Vps27) Benign brain tumours 
(e.g. Schwannomas, 
meningiomas, 
ependymomas) 
Interaction with 
neurofibromatosis 2 tumour 
suppressor protein 
schwannomin/merlin, regulating 
STAT signalling13, 14 
Human cancer 
cells, rat cells 
ESCRT-I Vps37A  Hepatocellular ca. (HCC) 
and metastasis 
Growth inhibitory protein, 
suppressing proliferation, 
transformation and invasion; 
strongly reduced levels in HCC2 
Human tissue 
and cancer cells 
 Tsg101 (Vps23) Ovarian cancer Up regulation of Tsg101: 
suppression of p21 expression and 
posttranslational regulation 
through MAPK signalling3, 4 
Human tissue 
and cancer cells 
 Tsg101 (Vps23) Mammary cancer Overexpression of Tsg101: 
increased signalling through 
MAPK5 
Human tissue, 
transgenic mice 
 Tsg101 (Vps23) Papillary thyroid cancer, 
gastrointestinal stromal 
tumours 
Overexpression of Tsg101 
(consequences not known)6, 7 
Human tissue 
ESCRT-I/II Erupted Tsg101/Vps25 Neoplastic transformation 
(ovary and imaginal 
discs), over-proliferation 
of adjacent WT cells 
Enhanced Notch and growth 
factor signalling in mutant cells8, 9, 
10 
Drosophila 
ESCRT-III CHMP3 (Vps24) Prostate cancer CHMP3 induces neuroendocrine 
cell differentiation11 
Human cells 
 CHMP3 (Vps24) Non-small cell lung 
cancer 
CHMP3 has a functional role in 
neuroendocrine cell 
differentiation12 
Human cancer 
cells 
ESCRT-III associated CHMP1A Ductal pancreatic cancer Tumour suppressor, regulating 
tumour growth potentially 
through p53 signalling pathway15 
Human cells, 
mice 
Neurodegenerative 
diseases 
    
ESCRT-I/III Tsg101 (Vps23) / 
CHMP3 (Vps24) / 
CHMP2B 
Neurodegeneration 
(FTLD-U, ALS, 
Huntington's disease 
(HD)) 
Reduced autophagic degradation, 
accumulation of Ub-protein 
aggregates containing TDP-43; 
reduced clearance of Huntington-
positive inclusions18 
Human cells, 
mouse cells 
ESCRT-I associated Tsg101 (Vps23) Spongiform 
neurodegeneration 
(hallmark of prion 
disease) 
E3 ubiquitin-protein ligase 
Mahogunin ubiquitinates Tsg101; 
depletion of Mahogunin disrupts 
endosomal trafficking21 
Human cells, rat 
tissue 
ESCRT-I associated Tsg101 (Vps23) Charcot-Marie-Tooth 
disease (CMT1C) 
Interaction with SIMPLE; SIMPLE 
plays a role in the lysosomal 
sorting of plasma membrane 
proteins22 
 
ESCRT-III CHMP2B (Vps2) FTLD-U and ALS Disruption of endosomal 
trafficking, protein 
accumulation16, 17 
Human cells 
 CHMP4B (Snf7-2) / 
CHMP2B 
Neurodegeneration 
(FTLD-U, ALS) 
Accumulation of 
autophagosomes; failure of 
mutant CHMP2B to dissociate 
properly leading to dysfunctional 
ESCRT-III on late endosomes20 
Drosophila, mice 
ESCRT-III associated CHMP1B Hereditary spastic Interaction with spastin; spastin Monkey cells 
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4.3.2 Viral infections 
The  beneficial role of ESCRTs’ in protecting against intracellular bacteria is reversed in viral 
infections. Many membrane-enveloped viruses hijack the ESCRT machinery to bud out of 
host cells. Retroviruses (HIV-1), filoviruses (Ebola virus), rhabdoviruses and arenaviruses 
encode short sequence motifs termed L-domains (late domains) within their structural (Gag) 
polyproteins that are essential for the release of assembled viruses from the host cells 
(reviewed by Carlton & Martin-Serrano, 2009; Stuffers et al., 2009b). The P(S/T)AP motif 
found on the HIV-1 Gag protein for example binds directly to the UEV domain of Tsg101 of 
ESCRT-I. Even though HIV-1 budding is normally ESCRT-I dependent, if Tsg101 is 
unavailable, the virus alternatively binds to Alix via the YPxL domain and buds (Stark et al., 
2003). Both ESCRT-I and Alix can independently recruit ESCRT-III, which together with 
Vps4 are required for efficient virus budding. Recent studies have shown that ESCRT-III 
and Vps4 can be recruited independently of either Tsg101 or Alix by the herpes simplex 
virus type-1 (Pawliczek & Crump et al., 2009) and the hepatitis C virus (Corless et al., 2010). 
ESCRT-II was found not to be essential for HIV- budding (Langelier et al., 2006), however 
ESCRT-II was discovered recently to be essential for release of the avian sarcoma virus 
(Pincetic et al., 2008). Other viruses such as the rabies virus can indirectly recruit the 
ESCRTs’ by using the PPxY motif to specifically recruit WW-domain-containing E3 
ubiquitin ligases of the Nedd4 family (Kikonyogo et al., 2001). Disruption of ESCRT function 
by RNA interference or dominant-negative Vps4 arrests viral release at the plasma 
membrane (Garrus et al., 2001; Martin-Serrano & Neil, 2011; Demirov et al., 2002; Strack et 
al., 2003; reviewed by Carlton & Martin-Serrano, 2009). Collectively, this data confirms that 
different enveloped viruses require specific proteins for budding and that the ESCRT 
machinery regulates viral release from the plasma membrane.   
5. Conclusions  
The ESCRT machinery is ubiquitous in eukaryotes and has been highly conserved in 
evolution due to its vital functions including endocytosis, cytokinesis and autophagy. Our 
understanding of the ESCRTs’’ roles in endocytosis, receptor downregulation, membrane 
deformation and scission has made great progress over the past few years and the study of 
various model systems has contributed significantly to this. We know that the ESCRTs’, in 
particular ESCRT-III and Vps4 have an intrinsic budding and scission activity that is 
focused on the neck of the ILVs and that they are important regulators of cytokinesis 
(Spitzer et al., 2006; Obita et al., 2007; Carlton & Martin-Serrano, 2007). Model systems have 
implicated the ESCRTs’ in autophagic fusion events and in endosome-lysosome 
degradation. Impaired function of these pathways causes various neurodegenerative 
disorders, cancers and is implicated in microbial infections. Genetic disruption of ESCRT-I, -
II and –III in mammalian and Drosophila systems has been shown to result in an 
accumulation of autophagosomes and toxic aggregates which accelerates neurodegeneration 
(Lee et al., 2007). Mutations in the ESCRT-III subunit CHMP2B, have been shown to cause 
FTD3 (Skibinski et al., 2005) and ALS (Parkinson et al., 2006). Furthermore, the ESCRTs’ and 
their associated proteins are also indirectly implicated in causing spongiform 
neurodegeneration (Kim, et al., 2007; Jiao et al., 2009), spastic paraplegia (Reid et al., 2005) 
and Niemann-Pick type C neurodegeneration (Ohsaki et al., 2006). Sustained receptor 
signaling is a key event in carcinogenesis, and Tsg101 (Li et al., 1997, Sun et al., 1997; Lin et 
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al., 1998), Vps37A (Xu et al., 2003) and CHMP1A (Li et al., 2009) have been identified as 
potential tumor suppressors. However several other subsequent studies found Tsg101 to 
play a role in cell cycle control, a conclusion that is in contradiction to the tumor suppressor 
properties of Tsg101 (Zhu et al., 2004). In Drosophila ESCRT-I and -II were found to behave 
as tumor suppressors (Li & Cohen, 1996; Xu et al., 2003; Li et al., 2008). Tissues expressing 
mutant ESCRT-I or -II were found to form tumors that are largely attributable to the cell 
non-automous stimulation of proliferation caused by excessive cytokine production by the 
mutant cells. This is triggered by overactive Notch signaling from endosomes, signifying 
that the ESCRT machinery is crucial for silencing Notch signaling and thereby for tumor 
suppression in flies. It has not yet been clarified whether this is the case in mammals. The 
ESCRTs’ were found to have a beneficial role in innate immunity by restricting microbial 
growth and infection (von Schwedler et al., 2003; Vieira et al., 2004; Philips et al., 2008; 
Morita & Sundquist, 2004; Martin-Serrano & Marsh, 2007; McCullough et al., 2008). The 
ESCRTs’ however, are turned against the host in viral infections. Several viruses, such as 
HIV-1 use the ESCRT components to bud out cells and cause infection (reviewed by Carlton 
& Martin-Serrano, 2009; Stuffers et al., 2009b). Further dissection of the roles of the ESCRTs’ 
in these events will shed light on the basic mechanism of vesicular traffic and provide new 
insights into disease pathogenesis and preventative and therapeutic strategies.  
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